Huapont Life Sciences Co.,Ltd. (SHE:002004)
China · Delayed Price · Currency is CNY 4.620
-0.030 (-0.65%)
May 22, 2026, 3:04 PM CST
Huapont Life Sciences Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 683.68 | 713.19 | -298.99 | 302.12 | 433.48 | 667.81 |
Depreciation & Amortization | 1,054 | 1,054 | 969.04 | 891.24 | 800.23 | 747.68 |
Other Amortization | 95.19 | 95.19 | 86.53 | 87.44 | 87.87 | 84.44 |
Loss (Gain) From Sale of Assets | -10.05 | -10.05 | -3.75 | -28.11 | 8.78 | -8.73 |
Asset Writedown & Restructuring Costs | 132.99 | 132.99 | 816.15 | 297.12 | 535.85 | 153.83 |
Loss (Gain) From Sale of Investments | -64.29 | -64.29 | 194.06 | -8.72 | -436.65 | -308.53 |
Provision & Write-off of Bad Debts | 82.24 | 82.24 | 20.68 | 7.61 | 7.26 | 19.31 |
Other Operating Activities | 692.9 | 486.79 | 362.92 | 740.56 | 1,112 | 719.48 |
Change in Accounts Receivable | -116.49 | -116.49 | -914.12 | -587.98 | 59.61 | -1,040 |
Change in Inventory | 186.23 | 186.23 | 317.41 | -201.92 | -154.58 | -456.09 |
Change in Accounts Payable | -540.44 | -540.44 | 153.83 | 190.68 | 1.46 | 645.38 |
Change in Other Net Operating Assets | 39.16 | 39.16 | 20.3 | -10.67 | 21.44 | 33.32 |
Operating Cash Flow | 2,273 | 2,096 | 1,625 | 1,589 | 2,408 | 1,270 |
Operating Cash Flow Growth | 46.47% | 28.96% | 2.25% | -33.99% | 89.65% | -46.49% |
Capital Expenditures | -574.92 | -638.28 | -956.27 | -1,284 | -1,131 | -1,256 |
Sale of Property, Plant & Equipment | 34.99 | 36.38 | 35.69 | 72.28 | 35.92 | 59.06 |
Cash Acquisitions | - | - | - | -3.95 | -15.84 | -41.4 |
Divestitures | - | - | 2.23 | - | - | 1.31 |
Investment in Securities | -780.1 | -806.5 | -413.96 | -321.82 | 584.97 | 301.12 |
Other Investing Activities | 114.4 | 130.11 | 187.13 | -212.1 | -30.37 | 145.91 |
Investing Cash Flow | -1,206 | -1,278 | -1,145 | -1,750 | -556.49 | -790.43 |
Short-Term Debt Issued | - | 225.22 | 253.64 | 561.7 | - | 15.4 |
Long-Term Debt Issued | - | 6,543 | 8,073 | 8,558 | 7,038 | 9,437 |
Total Debt Issued | 6,703 | 6,768 | 8,327 | 9,120 | 7,038 | 9,452 |
Short-Term Debt Repaid | - | -224.29 | -259.26 | -369.66 | -309.13 | -1,509 |
Long-Term Debt Repaid | - | -7,807 | -7,642 | -8,071 | -7,898 | -10,279 |
Total Debt Repaid | -7,588 | -8,031 | -7,901 | -8,441 | -8,207 | -11,788 |
Net Debt Issued (Repaid) | -884.58 | -1,263 | 425.9 | 678.89 | -1,169 | -2,336 |
Common Dividends Paid | -655.07 | -668.5 | -754.37 | -756.28 | -854.41 | -859.41 |
Other Financing Activities | 789.35 | 653.36 | -355.77 | 73.73 | 653.38 | 2,991 |
Financing Cash Flow | -750.3 | -1,278 | -684.24 | -3.65 | -1,370 | -203.77 |
Foreign Exchange Rate Adjustments | -10 | 7.23 | 27.84 | 0.64 | 7.26 | 11.06 |
Net Cash Flow | 306.74 | -453.22 | -176.29 | -163.26 | 488.36 | 286.48 |
Free Cash Flow | 1,698 | 1,458 | 669.02 | 305.35 | 1,277 | 13.19 |
Free Cash Flow Growth | 121.89% | 117.90% | 119.10% | -76.08% | 9579.95% | -98.84% |
Free Cash Flow Margin | 14.75% | 12.66% | 5.73% | 2.63% | 9.65% | 0.11% |
Free Cash Flow Per Share | 0.86 | 0.74 | 0.34 | 0.15 | 0.65 | 0.01 |
Cash Income Tax Paid | 589.76 | 650.65 | 457.41 | 570.87 | 277.96 | 437.81 |
Levered Free Cash Flow | 836.6 | 881.75 | 130.53 | 471.25 | 1,290 | 122.24 |
Unlevered Free Cash Flow | 1,019 | 1,075 | 349.26 | 686.07 | 1,562 | 410.78 |
Change in Working Capital | -393.78 | -393.78 | -521.36 | -699.78 | -141.15 | -805.67 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.